Telaprevir Patent Expiration
Telaprevir is Used for treating chronic hepatitis C. It was first introduced by Vertex Pharmaceuticals Inc
Telaprevir Patents
Given below is the list of patents protecting Telaprevir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Incivek | US7820671 | Peptidomimetic protease inhibitors | Feb 25, 2025 | Vertex Pharms |
| Incivek | US8431615 | Dose forms | May 30, 2028 | Vertex Pharms |
| Incivek | US8529882 | Peptidomimetic protease inhibitors |
Aug 31, 2021
(Expired) | Vertex Pharms |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳